arrow
I

Ivano Mezzaroma

sapienza university of rome
H指数:32
被引数:3,647

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy, safety, and anti-inflammatory properties of the switch to a doravirine-based regimen among antiretroviral-experienced elderly people living with HIV-1: the DORAGE cohort
2025-02-180
OAAI
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
2023-06-014
OAAI
Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort

在病毒学控制的PLWH中切换到Bictegravir/恩曲他滨/替诺福韦Alafenamide富马酸盐后的免疫重建和安全代谢概况: 来自BICTEL队列的96周更新

2023-05-236
OAAI
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
2020-10-0181
OAAI
Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort

与raltegravir在HIV感染者中使用相关的真实结果: 来自RAL年龄队列60个月随访的结果

2020-02-255
PREAI